Standout Papers

FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma 2024 202641
  1. FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma (2024)
    Jiao Huang, Xiaona Fang et al. Cancer Research

Immediate Impact

51 standout
Sub-graph 1 of 22

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
2 intermediate papers

Works of Lanqi Gong being referenced

Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
2023
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
2022

Author Peers

Author Last Decade Papers Cites
Lanqi Gong 250 135 144 17 490
Chunhui Zhou 285 174 154 27 544
Bo Shen 259 135 86 17 532
Mengxuan Yang 268 150 226 26 561
Alexandra Fullár 255 135 167 15 511
Ru Ji 270 146 182 17 539
Wasfi Alrawashdeh 197 161 253 13 496
Sifan Zhang 254 198 167 18 561
Jing‐biao Wu 221 173 146 17 475
Jing Xu 369 165 106 18 529
Takahiro Heishi 294 115 201 16 570

All Works

Loading papers...

Rankless by CCL
2026